Supply Constraint of Sarilumab [Kevzara®]
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
Medicine name |
Kevzara
|
Active substance |
sarilumab
|
Therapeutic area (MeSH) |
Arthritis, Rheumatoid
|
Regulatory outcome |
Variation
|
DHPC type |
Medicine shortage
|
Human ATC code |
L04AC14
|
Dissemination date |
09/11/2021
|